Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Effects
Long-term use of depo-provera contraceptive injection may cause osteoporosis
December 12th, 2004
The U.S. Food and Drug Administration (FDA) announced on November 17, 2004, that a "black box" warning will be added to the labeling of Depo-Provera Contraceptive Injection, indicating that prolonged use may result in the loss of bone density. Although Depo-Provera Contraceptive Injection has been used for decades for birth control throughout the world and remains a safe and effective contraceptive, FDA and Pfizer, the drug's manufacturer, are taking this action to ensure that physicians and patients have access to this important information. The black box warning for Depo-Provera highlights that prolonged use of the drug may result in significant...
Source: Medical Letter on the CDC & FDA (2004-12-12)
|
